Sutro Biopharma and Boehringer Ingelheim BioXcellenceâ„¢ collaboration: Established first-in-class cell-free capabilities at commercial scale
Boehringer Ingelheim BioXcellence™ and Inc. today announced that they successfully applied Sutro’s proprietary cell-free expression technology on a commercial scale to manufacture luveltamab ...
Business Wire3d
Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment ...
Cell-based therapy improves outcomes in a pig model of heart attacks
In a large-animal model study, researchers have found that heart attack recovery is aided by the injection of heart muscle ...
CTMC and Syenex Launch Partnership to Accelerate Scalability of Cell Therapies
CTMC, a joint venture between MD Anderson Cancer Center and Resilience, has entered a partnership with Syenex to advance the ...
eLife6d
Dissociation of the nuclear basket triggers chromosome loss in aging yeast
In many organisms, aging is a clear risk factor for increased rates of chromosome mis-segregation, the main source of aneuploidy. Here, we report that old yeast mother c ...
News Medical on MSN5d
Heart attack recovery enhanced by human stem cell spheroids, study shows
In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...
CNET1d
Every Eye-Catching Piece of Next-Gen Tech Unveiled at CES 2025
The trade show is packed to the brim with innovative tech and sizzling new invention. Here's everything we want to see more ...